LifeSci Capital Starts Inhibrx Biosciences (INBX) at Outperform
Tweet
Share
E-mailGet Alerts INBX Hot Sheet
Price: $92.11 +4.23%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
LifeSci Capital initiates coverage on Inhibrx Biosciences (NASDAQ: INBX) with a Outperform rating and a price target of $200.00.
For an analyst ratings summary and ratings history on Inhibrx Biosciences click here. For more ratings news on Inhibrx Biosciences click here.
Shares of Inhibrx Biosciences closed at $119.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump approval at 33%, lowest of his presidency - Reuters/Ipsos
- TXO Energy Partners (TXO) PT Lowered to $19 at CapitalOne
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
